Samrat Pharmachem Ltd. | Small-cap | Basic Materials
₹349.95
-1.55%
| Samrat Pharmachem Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 2.9B
Gross Profit 191.1M 6.69%
Operating Income 95.9M 3.35%
Net Income 71.1M 2.49%

Balance Sheet Metrics

Total Assets 1.2B
Total Liabilities 496.9M
Shareholders Equity 718.0M
Debt to Equity 0.69

Cash Flow Metrics

Operating Cash Flow 1.3M
Free Cash Flow -106.0M

Revenue & Profitability Trend

Samrat Pharmachem Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 2.9B 2.8B 3.1B 2.2B 1.8B
Cost of Goods Sold 2.7B 2.7B 2.8B 1.9B 1.7B
Gross Profit 191.1M 76.8M 287.7M 280.8M 118.7M
Operating Expenses 66.5M 29.7M 29.0M 20.1M 12.8M
Operating Income 95.9M 18.7M 233.9M 237.8M 87.4M
Pre-tax Income 98.9M 25.2M 225.3M 236.0M 73.4M
Income Tax 27.7M 3.6M 59.0M 64.2M 20.1M
Net Income 71.1M 21.6M 166.3M 171.8M 53.3M
EPS (Diluted) - ₹7.00 ₹53.83 ₹55.62 ₹17.26

Income Statement Trend

Samrat Pharmachem Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 1.0B 1.0B 990.5M 712.6M 473.2M
Non-Current Assets 181.3M 191.7M 175.4M 133.5M 100.7M
Total Assets 1.2B 1.2B 1.2B 846.1M 574.0M
Liabilities
Current Liabilities 495.8M 564.0M 531.9M 373.3M 273.3M
Non-Current Liabilities 1.1M 3.4M 2.5M 4.6M 4.3M
Total Liabilities 496.9M 567.4M 534.5M 377.9M 277.6M
Equity
Total Shareholders Equity 718.0M 650.0M 631.4M 468.2M 296.4M

Balance Sheet Composition

Samrat Pharmachem Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 98.9M 25.2M 225.3M 236.0M 73.4M
Operating Cash Flow 1.3M -35.9M -90.3M 126.4M 119.7M
Investing Activities
Capital Expenditures -5.1M -6.5M -13.6M -12.0M -16.5M
Investing Cash Flow -3.7M -7.1M -32.0M -12.0M -16.5M
Financing Activities
Dividends Paid -3.1M -3.1M -3.1M - -
Financing Cash Flow 11.5M -105.1M 108.3M -12.7M -3.0M
Free Cash Flow -106.0M 87.5M -109.0M 162.0M 20.7M

Cash Flow Trend

Samrat Pharmachem Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 14.95
Price to Book 1.48
Price to Sales 0.37

Profitability Ratios

Profit Margin 2.49%
Operating Margin -0.05%
Return on Equity 10.40%
Return on Assets 4.93%

Financial Health

Current Ratio 2.08
Debt to Equity 13.81
Beta -0.13

Per Share Data

EPS (TTM) ₹23.00
Book Value per Share ₹232.02
Revenue per Share ₹925.24

Financial data is updated regularly. All figures are in the company's reporting currency.